Ads
related to: bevacizumab avastin- ENHERTU® Information
Learn More About ENHERTU® and How
it is Thought to Work.
- ENHERTU® Resources
Access Free Patient Resources Like
a Downloadable Brochure.
- ENHERTU® Safety Info
Important Side Effect Information
for Patients and Caregivers.
- ENHERTU® Data
Access Important Data on How
ENHERTU® Performed in Studies.
- ENHERTU® Information
Search results
Earnings call: Kamada Limited reports robust Q1 2024 growth By Investing.com
Investing.com· 2 days ago(NASDAQ:KMDA), a specialty biopharmaceutical company, has reported a strong start to the year with...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoISELIN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of & ...
Study: For treating retinopathy of prematurity, UB-led research proves that ranibizumab is safe
UB Reporter· 1 day agoA University at Buffalo researcher who is a leading expert on retinopathy of prematurity (ROP) has published a study that could change the standard of care for the condition. ROP occurs in low ...
Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoAgenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript May 7, 2024 Agenus Inc. beats earnings...
What to know about cervical cancer
Medical Xpress· 6 days agoPart of the reproductive system, the cervix connects the vagina to the uterus, also known as the womb. By collecting cervical cells (called the Pap smear...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343(Anti-Claudin18.2 ADC)as...
FOX 23 News Albany· 5 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives $46.43 Average Target Price from Analysts
ETF DAILY NEWS· 21 hours agoShares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight research firms that are covering the firm, Marketbeat ...
Trehalose is enabling life-changing protein therapeutics and exosomes
Nature· 4 days agoTrehalose is vital to the biopharma industry. Manufacturers of monoclonal antibodies and other protein therapeutics use this saccharide to stabilize molecules that would otherwise be degraded ...
SHP report claims hospitals overcharging for oncology drugs
Winston-Salem Journal· 3 days agoThe latest commissioned report by state Treasurer Dale Folwell — released Wednesday — determined...
Ad
related to: bevacizumab avastin